Oxstem logo

OxStem is a drug discovery company, spun-out from the University of Oxford in 2016, with the unique vision of developing small molecule therapeutics that augment repair mechanisms that already exist within the body. OxStem is developing drug candidates that can awaken endogenous cells to repair tissues affected by disease or injury to treat diseases such as Dementia, Heart Failure, Macular Degeneration (the leading cause of blindness in the developed world) and Oncology.

Contact Oxstem via their website

News archive

06/01/2020   C-suite Changes at OxStem Including New CSO Dr Ian Churcher...more

25/03/2019   OxStem Appoints Dr Stuart Collinson as Chief Executive Officer and Chairman...more

04/10/2018   OxStem Limited Establishes Two New Subsidiary Companies...more

26/07/2018   OxStem Cardio co-founder publishes work in the Journal of Clinical Investigation...more

20/07/2018   OxStem co-founder honoured by the Royal Society...more

09/10/2017   OxStem Limited Strengthens Management Team...more

22/06/2017   Oxstem joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code